Skip to main content
. 2022 Jul;10(13):735. doi: 10.21037/atm-21-6186

Table 2. Prevalence of gallstone (with 95% CI) in Chinese adults in 2017.

Characteristics Gallstone GB stones IHD stones EHD stones
N Crude prevalence (%) Standardized prevalence* (%) N Crude prevalence (%) Standardized prevalence (%) N Crude prevalence (%) Standardized prevalence (%) N Crude prevalence (‱) Standardized prevalence (‱)
Overall 516,994 4.73 (4.71–4.74) 5.13 (5.11–5.14) 394,647 3.65 (3.64–3.66) 4.09 (4.08–4.10) 125,704 1.15 (1.14–1.16) 1.16 (1.15–1.17) 1,159 1.06 (1.00–1.12) 1.36 (1.27–1.45)
Age group, years
   <30 59,216 2.09 (2.07–2.11) 2.11 (2.09–2.13) 29,126 1.03 (1.02–1.04) 1.05 (1.03–1.06) 30,341 1.07 (1.06–1.08) 1.07 (1.06–1.09) 59 0.21 (0.16–0.26) 0.21 (0.16–0.27)
   30–50 218,874 4.29 (4.28–4.31) 4.31 (4.30–4.33) 161,096 3.18 (3.17–3.20) 3.20 (3.19–3.22) 59,130 1.16 (1.15–1.17) 1.16 (1.15–1.17) 336 0.66 (0.59–0.73) 0.67 (0.60–0.74)
   50–70 200,629 7.43 (7.40–7.46) 7.44 (7.41–7.47) 170,234 6.45 (6.42–6.48) 6.46 (6.43–6.49) 31,831 1.18 (1.17–1.19) 1.18 (1.16–1.19) 572 2.12 (1.95–2.29) 2.14 (1.96–2.31)
   ≥70 38,275 12.3 (12.2–12.5) 12.4 (12.3–12.6) 34,191 11.5 (11.4–11.6) 11.6 (11.5–11.7) 4,402 1.42 (1.38–1.46) 1.42 (1.37–1.46) 192 6.19 (5.32–7.07) 6.43 (5.51–7.35)
   P value <0.001 <0.001 <0.001 <0.001
Gender
   Male 259,739 4.45 (4.43–4.47) 4.85 (4.83–4.87) 194,827 3.36 (3.35–3.38) 3.79 (3.77–3.81) 66,710 1.14 (1.13–1.15) 1.16 (1.15–1.17) 460 0.79 (0.72–0.86) 1 (0.90–1.10)
   Female 257,255 5.04 (5.03–5.06) 5.41 (5.38–5.43) 199,820 3.97 (3.95–3.99) 4.39 (4.37–4.42) 58,994 1.16 (1.15–1.17) 1.16 (1.15–1.17) 699 1.37 (1.27–1.47) 1.72 (1.57–1.86)
   P value <0.001 <0.001 0.026 <0.001
BMI, kg/m2
   ≤18.50 12,151 2.62 (2.57–2.66) 3.94 (3.84–4.04) 6,285 1.36 (1.32–1.39) 2.58 (2.50–2.66) 5,933 1.28 (1.24–1.31) 1.43 (1.38–1.48) 39 0.84 (0. 58–1.10) 1.98 (1.23–2.73)
   18.5–24.99 231,299 4.17 (4.16–4.19) 4.67 (4.65–4.69) 161,836 2.95(2.93–2.96) 3.48 (3.46–3.50) 71,097 1.28 (1.27–1.29) 1.30 (1.29–1.31) 607 1.10 (1.01–1.18) 1.45 (1.32–1.59)
   25.0–29.99 170,951 5.69 (5.66–5.71) 5.75 (5.72–5.78) 143,237 4.84 (4.81–4.86) 4.95 (4.92–4.98) 28,791 0.96 (0.95–0.97) 0.96 (0.94–0.97) 322 1.07 (0.95–1.19) 1.28 (1.12–1.44)
   ≥30 34,132 6.26 (6.19–6.32) 6.91 (6.82–7.00) 31,236 5.82 (5.76–5.88) 6.52 (6.44–6.61) 3,052 0.56 (0.54–0.58) 0.60 (0.58–0.63) 41 0.75 (0.52–0.98) 0.87 (0.57–1.18)
   P value <0.001 <0.001 0.099 <0.001
Fasting glucose, mmol/L
   <7 458,775 4.61 (4.60–4.62) 5.04 (5.03–5.06) 345,523 3.51 (3.49–3.52) 3.98 (3.96–3.99) 116,246 1.17 (1.16–1.17) 1.18 (1.17–1.19) 1,023 1.03 (0.96–1.09) 1.35 (1.26–1.45)
   ≥7 39,120 8.71 (8.63–8.80) 6.85 (6.72–6.99) 35,682 8.15 (8.07–8.23) 6.39 (6.26–6.52) 3,680 0.82 (0.79–0.85) 0.66 (0.62–0.71) 97 2.16 (1.73–2.59) 1.35 (1.05–1.65)
   Unknown 19,099 3.58 (3.53–3.63) 4.67 (4.59–4.76) 13,442 2.54 (2.49–2.58) 3.65 (3.57–3.73) 5,778 1.08 (1.05–1.11) 1.13 (1.09–1.17) 39 0.73 (0.50–0.96) 1.34 (0.80–1.89)
   P value <0.001 <0.001 <0.001 <0.001
Total triglyceride, mmol/L
   <2.27 411,292 4.68 (4.66–4.69) 5.07 (5.05–5.08) 307,679 3.53 (3.52–3.55) 3.97 (3.95–3.98) 106,438 1.21 (1.20–1.22) 1.22 (1.21–1.23) 954 1.08 (1.02–1.15) 1.38 (1.28–1.48)
   ≥2.27 87,048 5.53 (5.50–5.57) 5.83 (5.78–5.89) 74,111 4.78 (4.75–4.82) 5.13 (5.08–5.19) 13,374 0.85 (0.84–0.86) 0.86 (0.84–0.88) 169 1.07 (0.91–1.24) 1.31 (1.05–1.57)
   Unknown 18,654 3.27 (3.22–3.31) 4.9 (4.80–5.00) 12,857 2.26 (2.22–2.30) 3.86 (3.77–3.95) 5,892 1.03 (1.01–1.06) 1.14 (1.09–1.18) 36 0.63 (0.42–0.84) 1.23 (0.66–1.80)
   P value <0.001 <0.001 <0.001 0.005
City scale
   Small or medium sized city 146,042 5.34 (5.32–5.37) 5.25 (5.22–5.28) 111,341 4.13 (4.10–4.15) 4.08 (4.05–4.11) 35,806 1.31 (1.30–1.32) 1.29 (1.28–1.31) 435 1.59 (1.44–1.74) 1.75 (1.57–1.93)
   Large city 198,340 4.35 (4.33–4.37) 4.75 (4.73–4.78) 157,615 3.50 (3.48–3.51) 3.93 (3.91–3.96) 41,794 0.92 (0.91–0.93) 0.93 (0.92–0.94) 398 0.87 (0.79–0.96) 1.13 (1.00–1.26)
   Mega city and above 172,612 4.73 (4.71–4.75) 5.57 (5.54–5.60) 125,691 3.48 (3.46–3.50) 4.39 (4.36–4.41) 48,104 1.32 (1.31–1.33) 1.32 (1.30–1.33) 326 0.89 (0.80–0.99) 1.31 (1.15–1.48)
   P value <0.001 <0.001 <0.001 <0.001

*, standardized prevalence: the age-standardized and gender-standardized prevalence was calculated according to data of China sixth census population 2010 using direct standardization method. Age-standardized prevalence was calculated for specific gender, sex-standardized prevalence was calculated for specific age group. BMI, body mass index; GB, gall bladder; IHD, intrahepatic bile duct; EHD, extrahepatic bile duct.